XML 48 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share-Based Awards - Schedule of Stock Option Activity (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2017
USD ($)
$ / shares
shares
Omnibus Plan | Series C  
Options Outstanding  
Outstanding, beginning balance (in shares) 193,998
Grants (in shares) 278,629
Exercised (in shares) 0
Forfeited (in shares) (10,000)
Outstanding, ending balance (in shares) 462,627
Outstanding, Weighted average exercise price (in dollars per share) | $ / shares $ 15.61
Outstanding, Weighted average remaining contractual life 9 years 9 months
Outstanding, Aggregate intrinsic value | $ $ 178
Exercisable (in shares) 0
Legacy Plans | Series C  
Options Outstanding  
Outstanding, beginning balance (in shares) 5,580,109
Grants (in shares) 0
Exercised (in shares) (55,655)
Forfeited (in shares) (46,494)
Outstanding, ending balance (in shares) 5,477,960
Outstanding, Weighted average exercise price (in dollars per share) | $ / shares $ 13.02
Outstanding, Weighted average remaining contractual life 7 years 11 months 20 days
Outstanding, Aggregate intrinsic value | $ $ 16,908
Exercisable (in shares) 1,261,320
Exercisable, Weighted average exercise price (in dollars per share) | $ / shares $ 3.45
Exercisable, Weighted average remaining contractual life 4 years 1 month 10 days
Exercisable, Aggregate intrinsic value | $ $ 15,236
Transitional Plan | Series C  
Options Outstanding  
Outstanding, beginning balance (in shares) 1,006,043
Grants (in shares) 0
Exercised (in shares) (119,028)
Forfeited (in shares) (3,558)
Outstanding, ending balance (in shares) 883,457
Outstanding, Weighted average exercise price (in dollars per share) | $ / shares $ 9.41
Outstanding, Weighted average remaining contractual life 4 years 2 months
Outstanding, Aggregate intrinsic value | $ $ 5,409
Exercisable (in shares) 476,669
Exercisable, Weighted average exercise price (in dollars per share) | $ / shares $ 7.23
Exercisable, Weighted average remaining contractual life 3 years 5 months
Exercisable, Aggregate intrinsic value | $ $ 3,956
Transitional Plan | Series A  
Options Outstanding  
Outstanding, beginning balance (in shares) 329,188
Grants (in shares) 0
Exercised (in shares) (59,532)
Forfeited (in shares) (1,785)
Outstanding, ending balance (in shares) 267,871
Outstanding, Weighted average exercise price (in dollars per share) | $ / shares $ 7.90
Outstanding, Weighted average remaining contractual life 3 years 8 months
Outstanding, Aggregate intrinsic value | $ $ 2,019
Exercisable (in shares) 204,631
Exercisable, Weighted average exercise price (in dollars per share) | $ / shares $ 6.46
Exercisable, Weighted average remaining contractual life 3 years
Exercisable, Aggregate intrinsic value | $ $ 1,835